Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis

Maroof Alam1, Swaleha Zubair2, Mohammad Farazuddin1, Ejaj Ahmad1, Arbab Khan1, Qamar Zia1, Abida Malik3, Owais Mohammad1
1Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, India
2Women’s College, Aligarh Muslim University, Aligarh, India
3Department of Microbiology, Jawaharlal Nehru Medical College, Aligarh, India

Tài liệu tham khảo

Anaissie, 1992, Opportunistic mycoses in the immunocompromised host: experience at cancer center and review, Clin Infect Dis, 14, 43, 10.1093/clinids/14.Supplement_1.S43 Pfaller, 1992, The impact of changing epidemiology of fungal infections in the 1990s, Eur J Clin Microbiol Infect Dis, 11, 287, 10.1007/BF01962067 Richardson, 1991, Opportunistic and pathogenic fungi, J Antimicrob Chemother, 28, 1, 10.1093/jac/28.suppl_A.1 Walsh, 1992, Invasive fungal infections: problems and challenges in developing new antifungal compound, 249 Prasad, 2005, Multidrug resistance in yeast Candida, Int Rev Cytol, 242, 215, 10.1016/S0074-7696(04)42005-1 Rex, 1995, Detection of amphotericin B-resistant Candida isolates in a broth-based system, Antimicrob Agents Chemother, 39, 906, 10.1128/AAC.39.4.906 Shah, 2005, The need for new therapeutic agents: what is in the pipeline?, Clin Microbiol Infect, 11, 36, 10.1111/j.1469-0691.2005.01141.x Yin, 1999, Inhibitory effect of seven Allium plants upon three Aspergillus species, Int J Food Microbiol, 49, 49, 10.1016/S0168-1605(99)00061-6 Reuter, 1996, Therapeutic effects and applications of garlic and its preparations, 135 Cavallito, 1944, Allicin, the antibacterial principle of Allium sativum, I: isolation, physical properties, and antibacterial action, J Am Chem Soc, 66, 1950, 10.1021/ja01239a048 Cavallito, 1945, Allicin, the antibacterial principle of Allium sativum, III: its precursor and “essential oil” of garlic, J Am Chem Soc, 67, 1032, 10.1021/ja01222a501 Cavallito, 1944, Allicin, the antibacterial principle of Allium sativum, II: determination of the chemical structure, J Am Chem Soc, 66, 1952, 10.1021/ja01239a049 Lawson, 1998, Garlic: a review of its medicinal effects and indicated active compounds, 176 Thomson, 2003, Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent, Curr Cancer Drug Targets, 3, 67, 10.2174/1568009033333736 Yoshida, 1999, An organosulphur compound isolated from oil-macerated garlic extract, and its antimicrobial effect, Biosci Biotechnol Biochem, 63, 588, 10.1271/bbb.63.588 Agarwal, 1996, Therapeutic actions of garlic constituents, Med Res Rev, 16, 111, 10.1002/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5 Tsao, 2001, In vitro antimicrobial activity of four Diallyl sulfides occurring naturally in garlic and chinese leek oils, J Med Microbiol, 50, 646, 10.1099/0022-1317-50-7-646 Avato, 2000, Allyl sulfide constituents of garlic volatile oil as antimicrobial agents, Phytomedicine, 7, 239, 10.1016/S0944-7113(00)80010-0 Naganawa, 1996, Inhibition of microbial growth by ajoene, sulfur-containing compound derived from garlic, Appl Environ Microbiol, 62, 4238, 10.1128/aem.62.11.4238-4242.1996 Lemar, 2007, Diallyl disulfide depletes glutathione in Candida albicans: oxidative stress-mediated cell death studied by two-photon microscopy, Yeast, 24, 695, 10.1002/yea.1503 Perini, 1996, Niosomes as carriers for ophthalmic drugs: in vitro/in vivo evaluation, Boll Chim Farm, 135, 145 Uchegbu, 1995, Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse, Pharm Res, 12, 1019, 10.1023/A:1016210515134 Rogerson, 1988, The distribution of doxorubicin in mice following administration in niosomes, J Pharm Pharmacol, 40, 337, 10.1111/j.2042-7158.1988.tb05263.x Chandraprakash, 1993, Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice, J Drug Target, 1, 143, 10.3109/10611869308996070 Luciani, 2004, Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes, Radiology, 231, 135, 10.1148/radiol.2311021559 Baillie, 1986, Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate, J Pharm Pharmacol, 38, 502, 10.1111/j.2042-7158.1986.tb04623.x Baillie, 1985, The preparation and properties of niosomes non-ionic surfactant vesicles, J Pharm Pharmacol, 37, 863, 10.1111/j.2042-7158.1985.tb04990.x Lawson, 1991, Identification and HPLC quantification of the sulpides and dialk(en)yl thiosulphinates in commercial garlic products, Planta Med, 57, 363, 10.1055/s-2006-960119 Nounou, 2006, In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels, Acta Pharm, 56, 311 Owais, 2000, Yeast vesicles as carriers for introducing macromolecules into cytoplasmic compartment of adherent cells, Eur J Biochem, 267, 3946, 10.1046/j.1432-1327.2000.01447.x Khan, 2003, Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B, J Drug Target, 11, 93, 10.1080/1061186031000119093 National Committee for Clinical Laboratory Standards, 1995 Khan, 2004, Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice, FEMS Immunol Med Microbiol, 41, 249, 10.1016/j.femsim.2004.03.011 Lopez-Berestein, 1984, Altered tissue distribution of Amphotericin-B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans, Cancer Drug Deliv, 1, 199, 10.1089/cdd.1984.1.199 Ahmad, 1989, Liposomal Amphotericin-B in the control of experimental aspergillosis in mice: part I—relative therapeutic efficacy of free and liposomal Amphotericin-B, Indian J Biochem Biophys, 26, 351 Kabara, 1977, Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides, Lipids, 12, 753, 10.1007/BF02570908 Bergsson, 2001, In vitro killing of Candida albicans by fatty acids and monoglycerides, Antimicrob Agents Chemother, 45, 3209, 10.1128/AAC.45.11.3209-3212.2001 Sahasrabudhe, 1969, Chromatographic analysis of sorbitan fatty acid esters, J Am Oil Chem Soc, 46, 8, 10.1007/BF02632701 Netea, 2010, Innate immune mechanisms for recognition and uptake of Candida species, Cell, 31, 346 Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359 Alam, 2009, Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice, Nanomedicine (Lond), 4, 713, 10.2217/nnm.09.60 Maroof, 2010, Potential use of liposomal diallyl sulfide in the treatment of experimental murine candidiasis, Biosci Rep, 30, 223, 10.1042/BSR20090068 Putman, 2000, Molecular properties of bacterial multidrug transporters, Microbiol Mol Biol Rev, 64, 672, 10.1128/MMBR.64.4.672-693.2000 Goren, 2000, Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump, Clin Cancer Res, 6, 1949